{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:56:58Z","timestamp":1792457818241,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013554","name":"Foundation for Women and Girls with Blood Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD043488"],"award-info":[{"award-number":["K12HD043488"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jtha.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T22:09:33Z","timestamp":1713478173000},"page":"1819-1825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Management of abnormal uterine bleeding on anticoagulation: the patient\u2013clinician perspective"],"prefix":"10.1016","volume":"22","author":[{"given":"Bethany T.","family":"Samuelson Bannow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jtha.2024.04.002_bib2","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jtha.2024.04.002_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","article-title":"Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death","volume":"37","author":"Arnesen","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jtha.2024.04.002_bib4","series-title":"Heavy menstrual bleeding: assessment and management","year":"2021"},{"key":"10.1016\/j.jtha.2024.04.002_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/aogs.12292","article-title":"Heavy menstrual bleeding significantly affects quality of life","volume":"93","author":"Karlsson","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2024.04.002_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.thromres.2015.07.030","article-title":"Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists","volume":"136","author":"De Crem","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.04.002_bib7","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.002_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.002_bib9","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ajog.2003.11.015","article-title":"Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data","volume":"190","author":"Warner","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.04.002_bib10","author":"Braithwaite"},{"key":"10.1016\/j.jtha.2024.04.002_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12905-018-0627-8","article-title":"A\u00a0systematic review of methods to measure menstrual blood loss","volume":"18","author":"Magnay","year":"2018","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jtha.2024.04.002_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jtha.2024.04.002_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2024.04.002_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.002_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.04.002_bib16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.002_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0149-2918(02)85026-3","article-title":"Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis","volume":"24","author":"Iskedjian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jtha.2024.04.002_bib18","first-page":"26","article-title":"Iron deficiency in menstruating adult women: much more than anemia","volume":"1","author":"Fernandez-Jimenez","year":"2020","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"10.1016\/j.jtha.2024.04.002_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4082\/kjfm.22.0206","article-title":"Period poverty: a neglected public health issue","volume":"44","author":"Jaafar","year":"2023","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.jtha.2024.04.002_bib21","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.3399\/BJGP.2022.0460","article-title":"Women\u2019s experiences of heavy menstrual bleeding and medical treatment: a qualitative study in primary care","volume":"73","author":"Dutton","year":"2023","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jtha.2024.04.002_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41430-021-01047-5","article-title":"Non-anemic iron deficiency: correlations between symptoms and iron status parameters","volume":"76","author":"Beatrix","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jtha.2024.04.002_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.04.002_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajh.26389","article-title":"Iron deficiency and fatigue among adolescents with bleeding disorders","volume":"97","author":"Zia","year":"2022","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2024.04.002_bib25","article-title":"The CLUES study: a critical look at understanding the emotional suffering of blood clot survivors [abstract]","volume":"6","author":"Rosovsky","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.002_bib26","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.04.002_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/13625187.2022.2112169","article-title":"Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations","volume":"27","author":"Tsakiridis","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jtha.2024.04.002_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.2023021717","article-title":"Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives","volume":"143","author":"Hugon-Rodin","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.002_bib29","doi-asserted-by":"crossref","first-page":"871.e1","DOI":"10.1016\/j.ajog.2022.05.022","article-title":"Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use","volume":"227","author":"Creinin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.04.002_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2018.12.008","article-title":"Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis","volume":"220","author":"Sergison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.04.002_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024597","article-title":"Effects of etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: results from a prospective, observational study","volume":"100","author":"Niu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtha.2024.04.002_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2024.04.002_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtha.2024.04.002_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rth2.12471","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: rationale and design of the MEDEA study","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.002_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12692","article-title":"Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron","volume":"6","author":"Elstrott","year":"2022","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:03:11Z","timestamp":1751356991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624002162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1538783624002162"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of abnormal uterine bleeding on anticoagulation: the patient\u2013clinician perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}